Large-scale testing (Phase 3)Ended earlyNCT02633293
What this trial is testing
An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
Who this might be right for
Pulmonary HypertensionInterstitial Lung DiseaseCombined Pulmonary Fibrosis and Emphysema
United Therapeutics 243